![Margaret J. Uprichard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Uprichard joined in January 2003 as Vice President, Clinical and Regulatory Affairs.
In December 2003, she was promoted to Senior Vice President, Clinical and Regulatory Affairs and in December 2004 to Senior Vice President, Drug Development to more reflect her responsibilities within Point.
Prior to joining, she founded a consulting company in drug development and served as Head of Regulatory, Clinical and/or Preclinical Affairs for both Curis, Inc and Paion, GmbH, from 2001-2003.
From 1990-2001, Dr. Uprichard held senior positions in both Clinical and Regulatory Affairs for Warner-Lambert/Pfizer in the oncology, neurology, cardiovascular, and rheumatology areas.
| Sociétés | Poste | Fin |
|---|---|---|
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Conseiller Juridique Général | 29/05/2008 |
Point Therapeutics, Inc.
 Point Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer and blood cell disorders | Directeur Technique/Scientifique/R&D | 26/03/2007 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Point Therapeutics, Inc.
Point Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer and blood cell disorders | Health Technology |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
